Unknown

Dataset Information

Cardiac Metastasis from Medullary Thyroid Cancers with Long-Term Survival under Vandetanib.


ABSTRACT:

Background

Cardiac metastases from thyroid cancers are uncommon with a poor prognosis. There is a lack of long-term follow-up studies.

Cases

We report 2 cases of cardiac metastasis from medullary thyroid cancer (MTC). Both patients presented limited metastatic disease apart from a cardiac metastasis. The initial diagnosis was challenging and was facilitated by functional imaging with an immuno-PET-CT using an anti-CEA bispecific antibody and a 68Ga-labeled peptide. Both patients were treated with the multitarget kinase inhibitor vandetanib with prolonged stability. The first patient was alive at the last follow-up, 14 years after the diagnosis of cardiac metastasis. The second patient required surgical excision of the cardiac mass because of disease progression un

SUBMITTER: Buffet C 

PROVIDER: S-EPMC8647102 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature